SI9520061B - Nova peptidna aktivna snov in njena priprava - Google Patents

Nova peptidna aktivna snov in njena priprava Download PDF

Info

Publication number
SI9520061B
SI9520061B SI9520061A SI9520061A SI9520061B SI 9520061 B SI9520061 B SI 9520061B SI 9520061 A SI9520061 A SI 9520061A SI 9520061 A SI9520061 A SI 9520061A SI 9520061 B SI9520061 B SI 9520061B
Authority
SI
Slovenia
Prior art keywords
pro
val
meval
terminal
formula
Prior art date
Application number
SI9520061A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9520061A (en
Inventor
Wilhelm Amberg
Harald Bernard
Ernst Buschmann
Andreas Haupt
Lothar Janitschke
Bernd Janssen
Ulrich Karl
Andreas Kling
Stefan Mueller
Potzolli Bernd De
Kurt Ritter
Marco Thyes
Thomas Zierke
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of SI9520061A publication Critical patent/SI9520061A/sl
Publication of SI9520061B publication Critical patent/SI9520061B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI9520061A 1994-05-06 1995-04-26 Nova peptidna aktivna snov in njena priprava SI9520061B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4415997A DE4415997A1 (de) 1994-05-06 1994-05-06 Neuer peptidischer Wirkstoff und dessen Herstellung
PCT/EP1995/001577 WO1995030691A1 (de) 1994-05-06 1995-04-26 Neuer peptidischer wirkstoff und dessen herstellung

Publications (2)

Publication Number Publication Date
SI9520061A SI9520061A (en) 1997-06-30
SI9520061B true SI9520061B (sl) 2002-02-28

Family

ID=6517453

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520061A SI9520061B (sl) 1994-05-06 1995-04-26 Nova peptidna aktivna snov in njena priprava

Country Status (28)

Country Link
US (1) US5864012A (pt)
EP (1) EP0758342B1 (pt)
JP (1) JPH09512803A (pt)
KR (1) KR100336139B1 (pt)
CN (1) CN1113067C (pt)
AT (1) ATE188485T1 (pt)
AU (1) AU688037B2 (pt)
BG (1) BG61610B2 (pt)
BR (1) BR9507623A (pt)
CZ (1) CZ288448B6 (pt)
DE (2) DE4415997A1 (pt)
DK (1) DK0758342T3 (pt)
ES (1) ES2141351T3 (pt)
FI (1) FI119642B (pt)
GR (1) GR3032630T3 (pt)
HR (1) HRP950271B1 (pt)
HU (1) HU220875B1 (pt)
IL (1) IL113544A (pt)
MX (1) MX9605402A (pt)
NO (1) NO317728B1 (pt)
NZ (1) NZ285092A (pt)
PL (1) PL180652B1 (pt)
PT (1) PT758342E (pt)
RU (1) RU2153504C2 (pt)
SI (1) SI9520061B (pt)
TW (1) TW408132B (pt)
WO (1) WO1995030691A1 (pt)
ZA (1) ZA953584B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US7304750B2 (en) * 1999-12-17 2007-12-04 Nektar Therapeutics Systems and methods for non-destructive mass sensing
KR20020066476A (ko) * 2001-02-12 2002-08-19 쥬가이 세이야쿠 가부시키가이샤 펩타이드 유도체의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2136339C (en) * 1992-05-20 2008-02-05 Andreas Haupt Derivatives of dolastatin

Also Published As

Publication number Publication date
NO964688L (no) 1997-01-02
PT758342E (pt) 2000-04-28
CZ288448B6 (en) 2001-06-13
KR970702880A (ko) 1997-06-10
ES2141351T3 (es) 2000-03-16
NZ285092A (en) 1998-01-26
DE4415997A1 (de) 1995-11-09
EP0758342B1 (de) 2000-01-05
FI119642B (fi) 2009-01-30
DE59507578D1 (de) 2000-02-10
BG61610B2 (bg) 1998-01-30
AU2408395A (en) 1995-11-29
HU9603067D0 (en) 1997-01-28
WO1995030691A1 (de) 1995-11-16
NO317728B1 (no) 2004-12-13
DK0758342T3 (da) 2000-05-01
CN1113067C (zh) 2003-07-02
IL113544A0 (en) 1995-07-31
HUT75861A (en) 1997-05-28
IL113544A (en) 2001-01-11
CN1162318A (zh) 1997-10-15
HRP950271A2 (en) 1997-08-31
MX9605402A (es) 1997-12-31
HRP950271B1 (en) 2000-08-31
ZA953584B (en) 1996-11-04
EP0758342A1 (de) 1997-02-19
PL180652B1 (pl) 2001-03-30
FI964448A0 (fi) 1996-11-05
FI964448A (fi) 1996-11-05
RU2153504C2 (ru) 2000-07-27
PL321159A1 (en) 1997-11-24
HU220875B1 (en) 2002-06-29
TW408132B (en) 2000-10-11
US5864012A (en) 1999-01-26
JPH09512803A (ja) 1997-12-22
BR9507623A (pt) 1997-10-07
AU688037B2 (en) 1998-03-05
GR3032630T3 (en) 2000-05-31
KR100336139B1 (ko) 2002-09-25
SI9520061A (en) 1997-06-30
NO964688D0 (no) 1996-11-05
ATE188485T1 (de) 2000-01-15
CZ326096A3 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
AU4799793A (en) Beta -aminoalkyl and beta -n-peptidylaminoalkyl boronic acids
HUT77372A (hu) Új benzil-pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
CA2083305A1 (en) Pharmaceutical compositions for oral use and method of preparing them
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
AU666801B2 (en) New peptide compounds derived from boronic acid, process for preparing them and pharmaceutical compositions containing them
CA2125251A1 (en) A pharmaceutical composition for angiotensin ii-mediated diseases
GB0216539D0 (en) Compositions
SG160212A1 (en) Process for the preparation of n-substituted 2-cyanopyrrolidines
SI9520061B (sl) Nova peptidna aktivna snov in njena priprava
AU1930497A (en) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
RU96123123A (ru) Новое пептидное активное вещество и его получение
EP1310490A4 (en) GPR14 ANTAGONIST
CA2231633A1 (en) Process for the preparation of anti-malarial drugs
PL312252A1 (en) Positive inotropic and lusitropic derivatives of pyrrole quinolone
IE850116L (en) Aspartic acid derivatives
TNSN05261A1 (en) Process for the preparation of n-substituted 2-cyanopyrrolidines
GEP20074100B (en) Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising the same
PL353926A1 (en) Process for the preparation of 2-cyanopyridines
MY102090A (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
CA2073189A1 (en) N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition
GB9523637D0 (en) Synthesis of carboxylic acid derivatives
AU5636098A (en) New benzenesulfonylamine compounds, process for preparing them and pharmaceutical compositions containing them
JPS55164671A (en) Azetidine derivative and its preparation
GB1434645A (en) Tetrazole coumarin derivatives
GB9226857D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
IF Valid on the event date
SP73 Change of data on owner

Owner name: ABBVIE DEUTSCHLAND GMBH & CO. KG; DE

Effective date: 20140307